ArticleBiochemical pharmacology2012

PARP inhibition potentiates the cytotoxic activity of C-1305, a selective inhibitor of topoisomerase II, in human BRCA1-positive breast cancer cells.

Józefa Węsierska-Gądek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.